×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
ReNeuron Group (LON:RENE) Stock Passes Below 200 Day Moving Average of $3.96
Defense World
Read ReNeuron Group (LON:RENE) Stock Passes Below 200 Day Moving Average of $3.96 at Defense World.
5 days ago
Reneuron issues administration warning as biotech firm puts jobs at risk
Yahoo Finance UK
Biotech business ReNeuron Group has warned it could enter administration and is preparing to make redundancies as its shares were suspended...
3 months ago
ReNeuron Group plc (LON:RENE) Is Expected To Breakeven In The Near Future
Simply Wall Street
Expectations from some of the British Biotechs analysts is that ReNeuron Group is on the verge of breakeven. They expect the company to post a...
7 months ago
ReNeuron may have a future as a listed company, investors and creditors told
Proactive Investors
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF), the stem cell group placed into administration in March, said it is exploring an equity fundraiser...
2 weeks ago
Redundancies at stem cell firm as it fights for life
BusinessCloud
Options at ReNeuron Group plc, placed into administration in March, include sale of assets or fresh fundraise to operate on lower-cost...
2 weeks ago
ReNeuron Group (LON:RENE) Stock Price Crosses Below 200-Day Moving Average of $4.05
Defense World
Read ReNeuron Group (LON:RENE) Stock Price Crosses Below 200-Day Moving Average of $4.05 at Defense World.
2 weeks ago
ReNeuron reaches exosome research milestone
Sharecast.com
UK-based biotechnology company ReNeuron Group, which specialises in stem cell-derived exosome technologies, announced significant...
8 months ago
Stem cell specialist CFO to step down
Insider Media Ltd
The chief financial officer of a listed stem cell research specialist headquartered in South Wales is to step down. ReNeuron Group plc...
1 month ago
ReNeuron shares suspended as urgent cash injection needed
Proactive Investors
ReNeuron Group PLC (AIM:RENE, OTC:RNUGF) said it has requested its shares be suspended pending clarification of its financial position.
3 months ago
ReNeuron lays off 40% of staff after funding failure, buying time to execute exosome pivot
Fierce Biotech
Iain Ross has made an immediate mark on ReNeuron, overseeing a restructuring to reduce the British biotech's head count by 40% within weeks...
16 months ago